Dysphagia following chemoradiation for locally advanced head and neck cancer

被引:234
作者
Nguyen, NP
Moltz, CC
Frank, C
Vos, P
Smith, HJ
Karlsson, U
Dutta, S
Midyett, FA
Barloon, J
Saw, S
机构
[1] VA N Texas Hlth Care Syst, Radiat Oncol Serv, Dallas, TX USA
[2] VA N Texas Hlth Care Syst, Audiol & Speech Pathol Serv, Dallas, TX USA
[3] VA N Texas Hlth Care Syst, Serv Radiol, Dallas, TX USA
[4] VA N Texas Hlth Care Syst, Dietet Serv, Dallas, TX USA
[5] E Carolina Univ, Dept Biostat, Greenville, NC USA
[6] E Carolina Univ, Dept Radiat Oncol, Greenville, NC USA
[7] Plano Canc Ctr, Dept Radiat Oncol, Plano, TX USA
[8] Louisiana State Univ, Div Hematol Oncol, Shreveport, LA 71105 USA
关键词
aspiration; chemoradiation; dysphagia; head and neck cancer;
D O I
10.1093/annonc/mdh101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To assess the prevalence, severity and morbidity of dysphagia following concurrent chemoradiation for head and neck cancer. Patients and methods: Patients who underwent chemotherapy and radiation for head and neck malignancies were evaluated for their ability to resume oral feeding following treatment. Modified barium swallow (MBS) studies were performed if the patients complained of dysphagia or if there was clinical suspicion of aspiration. The severity of dysphagia was graded on a scale of 1-7. If significant abnormalities were found, swallowing studies were repeated until resolution of dysphagia. Results: Between March 1999 and May 2002, 55 patients with locally advanced head and neck cancer underwent concurrent chemotherapy and radiation. Aspiration pneumonia was observed in eight patients, three during treatment and five following treatment. Five patients died from pneumonia. Two patients developed respiratory failure requiring intubation as a complication of pneumonia. At a median follow-up of 17 months (range 6-48 months), 25 patients (45%) developed severe dysphagia requiring prolonged tube feedings for more than 3 months (22 patients) or repeated dilatations (three patients). Among 33 patients who underwent MBS following treatment, 12 patients (36%) had silent aspiration (grade 6-7 dysphagia). Thirteen patients (39%) developed grade 4-5 dysphagia which required prolonged enteral nutritional support to supplement their oral intake. Most patients had severe weight loss (0-21 kg) during treatment, likely due in part to mucositis in the orodigestive tube. Conclusions: Dysphagia is a common, debilitating and potentially life-threatening sequela of concurrent chemoradiation for head and neck malignancy. Physicians should be aware that the clinical manifestations of aspiration may be unreliable and insidious, because of the depressed cough reflex. Modified and traditional barium swallows should be performed following treatment to assess the safety of oral feeding and the structural integrity of the pharynx and esophagus. Patients with severe dysphagia may benefit from rehabilitation. Tube feeding should be continued for those with aspiration.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 31 条
  • [1] Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma
    Ackerstaff, AH
    Tan, IB
    Rasch, CRN
    Balm, AJM
    Keus, RB
    Schornagel, JH
    Hilgers, FJM
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (10) : 1185 - 1190
  • [2] Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
    Adelstein, DJ
    Li, Y
    Adams, GL
    Wagner, H
    Kish, JA
    Ensley, JF
    Schuller, DE
    Forastiere, AA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 92 - 98
  • [3] Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy
    Adelstein, DJ
    Saxton, JP
    Lavertu, P
    Rybicki, LA
    Esclamado, RM
    Wood, BG
    Strome, M
    Carroll, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1405 - 1410
  • [4] Al-Sarraf Muhyi, 2002, Cancer Control, V9, P387
  • [5] Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
    Brizel, DM
    Albers, ME
    Fisher, SR
    Scher, RL
    Richtsmeier, WJ
    Hars, V
    George, SL
    Huang, AT
    Prosnitz, LR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) : 1798 - 1804
  • [6] Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer
    Büntzel, J
    Glatzel, M
    Kuttner, K
    Weinaug, R
    Fröhlich, D
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 4 - 13
  • [7] Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
    Eisbruch, A
    Lyden, T
    Bradford, CR
    Dawson, LA
    Haxer, MJ
    Miller, AE
    Teknos, TN
    Chepeha, DB
    Hogikyan, ND
    Terrell, JE
    Wolf, GT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01): : 23 - 28
  • [8] Karnell MPME., 1994, AM J SPEECH-LANG PAT, V3, P54, DOI [10.1044/1058-0360.0302.54, DOI 10.1044/1058-0360.0302.54]
  • [9] Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
    Kies, MS
    Haraf, DJ
    Rosen, F
    Stenson, K
    List, M
    Brockstein, B
    Chung, T
    Mittal, BB
    Pelzer, H
    Portugal, L
    Rademaker, A
    Weichselbaum, R
    Vokes, EE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 1961 - 1969
  • [10] Pharyngeal transport dysfunction consequent to an organ-sparing protocol
    Kotz, T
    Abraham, S
    Beitler, JJ
    Wadler, S
    Smith, RV
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (04) : 410 - 413